Published in Mediators Inflamm on July 14, 2013
Reperfusion injury and reactive oxygen species: The evolution of a concept. Redox Biol (2015) 1.19
Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats. J Neuroinflammation (2014) 0.98
Intrathecal antagonism of microglial TLR4 reduces inflammatory damage to blood-spinal cord barrier following ischemia/reperfusion injury in rats. Mol Brain (2014) 0.97
Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats. Mol Brain (2014) 0.86
Expression of C5a and its receptor following spinal cord ischemia reperfusion injury in the rat. Spinal Cord (2015) 0.84
MiR-27a ameliorates inflammatory damage to the blood-spinal cord barrier after spinal cord ischemia: reperfusion injury in rats by downregulating TICAM-2 of the TLR4 signaling pathway. J Neuroinflammation (2015) 0.83
Inflammogenesis of Secondary Spinal Cord Injury. Front Cell Neurosci (2016) 0.78
Inflammation Level after Decompression Surgery for a Rat Model of Chronic Severe Spinal Cord Compression and Effects on Ischemia-Reperfusion Injury. Neurol Med Chir (Tokyo) (2015) 0.77
PMX53 protects spinal cord from ischemia-reperfusion injury in rats in the short term. Spinal Cord (2015) 0.75
Mesenteric vascular dysregulation and intestinal inflammation accompanies experimental spinal cord injury. Am J Physiol Regul Integr Comp Physiol (2016) 0.75
Down-Regulation of CXCL12/CXCR4 Expression Alleviates Ischemia-Reperfusion-Induced Inflammatory Pain via Inhibiting Glial TLR4 Activation in the Spinal Cord. PLoS One (2016) 0.75
Spinal Cord Inflammation: Molecular Imaging after Thoracic Aortic Ischemia Reperfusion Injury. Radiology (2016) 0.75
Enhancing excitatory activity of somatosensory cortex alleviates neuropathic pain through regulating homeostatic plasticity. Sci Rep (2017) 0.75
Tat-protein disulfide-isomerase A3: a possible candidate for preventing ischemic damage in the spinal cord. Cell Death Dis (2017) 0.75
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature (1997) 3.75
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci (2001) 3.55
Management and preparedness for infusion and hypersensitivity reactions. Oncologist (2007) 2.29
Managing premedications and the risk for reactions to infusional monoclonal antibody therapy. Oncologist (2008) 1.93
Comparison of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury. Intensive Care Med (2011) 1.60
Tumor necrosis factor-alpha induces cFOS and strongly potentiates glutamate-mediated cell death in the rat spinal cord. Neurobiol Dis (2001) 1.36
Immunology in clinic review series; focus on autoinflammatory diseases: update on monogenic autoinflammatory diseases: the role of interleukin (IL)-1 and an emerging role for cytokines beyond IL-1. Clin Exp Immunol (2012) 1.30
Effects of interleukin-10 (IL-10) on pain behavior and gene expression following excitotoxic spinal cord injury in the rat. Exp Neurol (2001) 1.29
Acute infusion reactions induced by monoclonal antibody therapy. Expert Rev Clin Immunol (2011) 1.21
Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation. Ann Surg (2000) 1.17
Beneficial effects of hydrogen gas against spinal cord ischemia-reperfusion injury in rabbits. Brain Res (2010) 1.05
Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits. J Vasc Surg (2008) 1.04
The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation (2012) 1.03
Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits. Spinal Cord (2002) 1.02
Anti-TNF treatment in rheumatoid arthritis. Curr Pharm Des (2011) 1.01
Molecular hydrogen as an emerging therapeutic medical gas for neurodegenerative and other diseases. Oxid Med Cell Longev (2012) 1.01
Inhibition of extracellular signal-regulated kinases 1/2 provides neuroprotection in spinal cord ischemia/reperfusion injury in rats: relationship with the nuclear factor-kappaB-regulated anti-apoptotic mechanisms. J Neurochem (2010) 0.98
Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits. J Vasc Surg (2013) 0.95
Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1. Acta Pharmacol Sin (2011) 0.95
Panax notoginsenoside produces neuroprotective effects in rat model of acute spinal cord ischemia-reperfusion injury. J Ethnopharmacol (2011) 0.92
Inhibition of the MEK/ERK pathway reduces microglial activation and interleukin-1-beta expression in spinal cord ischemia/reperfusion injury in rats. J Thorac Cardiovasc Surg (2007) 0.92
Tetramethylpyrazine protects spinal cord and reduces inflammation in a rat model of spinal cord ischemia-reperfusion injury. J Vasc Surg (2011) 0.92
Injection-site reactions upon Kineret (anakinra) administration: experiences and explanations. Rheumatol Int (2011) 0.91
Evolution of spinal cord injury in a porcine model of prolonged aortic occlusion. J Surg Res (2005) 0.90
Immune response by microglia in the spinal cord. Ann N Y Acad Sci (2010) 0.89
The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation. J Thorac Cardiovasc Surg (2004) 0.89
Altered microRNA expression in the ischemic-reperfusion spinal cord with atorvastatin therapy. J Pharmacol Sci (2013) 0.88
The temporal profile of the reaction of microglia, astrocytes, and macrophages in the delayed onset paraplegia after transient spinal cord ischemia in rabbits. Anesth Analg (2003) 0.88
Atrial natriuretic peptide reduces ischemia/reperfusion-induced spinal cord injury in rats by enhancing sensory neuron activation. J Pharmacol Exp Ther (2007) 0.88
Adenosine A2A analogue ATL-146e reduces systemic tumor necrosing factor-alpha and spinal cord capillary platelet-endothelial cell adhesion molecule-1 expression after spinal cord ischemia. J Vasc Surg (2002) 0.87
The effects of systemic hypothermia on a murine model of thoracic aortic ischemia reperfusion. J Vasc Surg (2010) 0.86
Neuroprotective effects of infliximab in experimental spinal cord ischemic injury. J Clin Neurosci (2010) 0.86
Acute effect of Ghrelin on ischemia/reperfusion injury in the rat spinal cord. Int J Mol Sci (2012) 0.85
Prevention of endothelial cell injury by activated protein C: the molecular mechanism(s) and therapeutic implications. Curr Vasc Pharmacol (2004) 0.84
Analysis of serum pro-inflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue damage. Turk Neurosurg (2009) 0.83
Lazaroid reduces production of IL-8 and IL-1 receptor antagonist in ischemic spinal cord injury. Ann Thorac Surg (2000) 0.82
The effects of splenectomy on lipid peroxidation and neuronal loss in experimental spinal cord ischemia/reperfusion injury. Turk Neurosurg (2013) 0.81
Aortic cross-clamping-induced spinal cord oxidative stress in rabbits: the role of a novel antioxidant adrenomedullin. J Surg Res (2007) 0.81
Antithrombin reduces the ischemia/reperfusion-induced spinal cord injury in rats by attenuating inflammatory responses. Thromb Haemost (2004) 0.81
Effect of heparin on neuroprotection against spinal cord ischemia and reperfusion in rats. Eur Rev Med Pharmacol Sci (2013) 0.81
Proinflammatory cytokines in cerebrospinal fluid in repair of thoracoabdominal aorta. Ann Thorac Surg (2001) 0.81
The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits. Anesth Analg (2006) 0.80
The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model. Spinal Cord (2006) 0.80
Systemic administration of interleukin-10 attenuates early ischemic response following spinal cord ischemia reperfusion injury in rats. J Surg Res (2008) 0.79
The neuroprotective and anti-inflammatory effects of diltiazem in spinal cord ischaemia-reperfusion injury. J Int Med Res (2009) 0.78
Transient ischemia-induced paresis and complete paraplegia displayed distinct reactions of microglia and macrophages. Brain Res (2011) 0.78
Functional protection of pentoxifylline against spinal cord ischemia/reperfusion injury in rabbits: necrosis and apoptosis effects. Chin Med J (Engl) (2008) 0.77
Adenosine 2A receptor modulates inflammation and phenotype in experimental abdominal aortic aneurysms. FASEB J (2013) 0.76
Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res (2010) 2.77
Gene expression profile in the regenerating rat liver after partial hepatectomy. J Hepatol (2003) 2.43
Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends (2010) 2.01
Amelioration of experimental autoimmune encephalomyelitis in Lewis rats by FTY720 treatment. J Pharmacol Exp Ther (2003) 1.73
Nephritis-associated plasmin receptor and acute poststreptococcal glomerulonephritis: characterization of the antigen and associated immune response. J Am Soc Nephrol (2004) 1.67
Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Transplantation (2007) 1.56
Simplified technique for heterotopic vascularized cervical heart transplantation in mice. Microsurgery (2005) 1.51
Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transpl (2012) 1.49
Palliative arterial switch for transposition of the great arteries, ventricular septal defect, and pulmonary vascular obstructive disease: midterm outcomes. J Thorac Cardiovasc Surg (2010) 1.44
Inhibitory effects of calcitonin gene-related peptides on experimental vein graft disease. Ann Thorac Surg (2010) 1.39
Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. Mol Biol Cell (2005) 1.17
Long-term post-stroke changes include myelin loss, specific deficits in sensory and motor behaviors and complex cognitive impairment detected using active place avoidance. PLoS One (2013) 1.04
Molecular epidemiology of HIV type 1 in treatment-naive patients in north Ethiopia. AIDS Res Hum Retroviruses (2007) 1.02
Immunosuppressive and anti-inflammatory activities of sinomenine. Int Immunopharmacol (2010) 1.01
A TaqMan-based real-time polymerase chain reaction for the detection of porcine parvovirus. J Virol Methods (2008) 1.01
Minimal standard terminology for gastrointestinal endoscopy - MST 3.0. Endoscopy (2009) 0.99
Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. PLoS One (2013) 0.98
Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production. Int Immunopharmacol (2009) 0.93
Superagonist CD28 antibody preferentially expanded Foxp3-expressing nTreg cells and prevented graft-versus-host diseases. Cell Transplant (2009) 0.91
Hydrogen-rich University of Wisconsin solution attenuates renal cold ischemia-reperfusion injury. Transplantation (2012) 0.90
Porous titanium-6 aluminum-4 vanadium cage has better osseointegration and less micromotion than a poly-ether-ether-ketone cage in sheep vertebral fusion. Artif Organs (2013) 0.89
Determination of specific activities and kinetic constants of biotinidase and lipoamidase in LEW rat and Lactobacillus casei (Shirota). J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.89
Distinct pathways of apoptosis triggered by FTY720, etoposide, and anti-Fas antibody in human T-lymphoma cell line (Jurkat cells). J Pharmacol Exp Ther (2002) 0.87
Inhibition of allogeneic T-cell responses by dendritic cells expressing transduced indoleamine 2,3-dioxygenase. J Gene Med (2005) 0.87
Ventricular repolarization lability in children with Kawasaki disease. Pediatr Cardiol (2011) 0.86
Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells. Transplantation (2012) 0.86
IFN-γ deficiency attenuates hepatic inflammation and fibrosis in a steatohepatitis model induced by a methionine- and choline-deficient high-fat diet. Am J Physiol Gastrointest Liver Physiol (2013) 0.86
Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation (2002) 0.86
A superagonistic monoclonal antibody for CD28 ameliorates crescentic glomerulonephritis in wistar-kyoto rats. Mol Med (2011) 0.86
Differences in lymphocyte gene expression between tolerant and syngeneic liver grafted rats. Liver Transpl (2004) 0.84
Prolonged survival of rat liver allograft with adenoviral gene transfection of human immunodeficiency virus type 1 nef. Liver Transpl (2003) 0.84
18F-FDG PET for semiquantitative evaluation of acute allograft rejection and immunosuppressive therapy efficacy in rat models of liver transplantation. J Nucl Med (2009) 0.84
Changes in atrial natriuretic peptide levels during cardiac bypass in the fetal goat. Artif Organs (2008) 0.83
Prolongation of rat major histocompatibility complex-compatible cardiac allograft survival during pregnancy. J Heart Lung Transplant (2009) 0.83
Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood. J Lab Clin Med (2005) 0.83
Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody can prevent rat cardiac allograft rejection. J Heart Lung Transplant (2008) 0.83
The role of CD98hc in mouse macrophage functions. Cell Immunol (2012) 0.83
Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation. Transpl Immunol (2003) 0.82
Human umbilical cord blood-derived cells differentiate into hepatocyte-like cells in the Fas-mediated liver injury model. Am J Physiol Gastrointest Liver Physiol (2005) 0.82
Spontaneous tolerance involving natural killer T cells after hepatic grafting in mice. Transpl Immunol (2007) 0.82
Prevention of graft-versus-host diseases by in vivo supCD28mAb-expanded antigen-specific nTreg cells. Cell Transplant (2010) 0.82
Induction of donor-specific tolerance using superagonistic CD28 antibody in rat renal allografts: regulatory T-cell expansion before engraftment may be important. Transplantation (2010) 0.81
Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats. Cell Transplant (2012) 0.81
Curcumin has bright prospects for the treatment of multiple sclerosis. Int Immunopharmacol (2010) 0.81
Accuracy of the ultrasonic cardiac output monitor in healthy term neonates during postnatal circulatory adaptation. Chin Med J (Engl) (2011) 0.81
Advanced oxidation protein products as prognostic biomarkers for recovery from acute kidney injury after coronary artery bypass grafting. Biomarkers (2012) 0.81
Gene expression profile analysis of the peripheral blood mononuclear cells from tolerant living-donor liver transplant recipients. Int Surg (2008) 0.81
The effects of Foxp3-expressing regulatory T cells expanded with CD28 superagonist antibody in DSS-induced mice colitis. Int Immunopharmacol (2010) 0.81
5-Aminolevulinic acid combined with ferrous iron induces carbon monoxide generation in mouse kidneys and protects from renal ischemia-reperfusion injury. Am J Physiol Renal Physiol (2013) 0.80
Anergic lymphocytes generated by blocking CD28 and ICOS pathways in vitro prolong rat cardiac graft survival. Int Immunopharmacol (2006) 0.80
Histopathological and behavioral improvement of murine mucopolysaccharidosis type VII by intracerebral transplantation of neural stem cells. Mol Ther (2005) 0.80
Metron factor-1 prevents liver injury without promoting tumor growth and metastasis. Hepatology (2008) 0.80
Transcatheter closure of coronary arterial fistula in children and adolescents. Pediatr Int (2014) 0.80
Beat-to-beat QT interval variability in children: normal and physiologic data. J Electrocardiol (2010) 0.80
[(11)C]DAC-PET for noninvasively monitoring neuroinflammation and immunosuppressive therapy efficacy in rat experimental autoimmune encephalomyelitis model. J Neuroimmune Pharmacol (2011) 0.79
Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation. Liver Transpl (2004) 0.79
Theaflavin attenuates ischemia-reperfusion injury in a mouse fatty liver model. Biochem Biophys Res Commun (2011) 0.79
Multimerized CHR-derived peptides as HIV-1 fusion inhibitors. Bioorg Med Chem (2013) 0.79
Preservation by desiccation of isolated rat hearts for 48 hours using carbon monoxide (PCO = 4,000 hPa) and oxygen (PO(2) = 3,000 hPa). Cell Transplant (2012) 0.79
Lysophosphatidylcholine upregulates LOX-1, chemokine receptors, and activation-related transcription factors in human T-cell line Jurkat. J Thromb Thrombolysis (2007) 0.79
[The effect of overall treatment time on local control in nasopharyngeal carcinoma patients treated with intensity modulated radiation therapy]. Zhonghua Yi Xue Za Zhi (2011) 0.78
Matrine inhibits vascular smooth muscle cell proliferation by modulating the expression of cell cycle regulatory genes. Acta Pharmacol Sin (2010) 0.78
Differential sensitivity of RIP3-proficient and deficient murine fibroblasts to camptothecin anticancer drugs. Acta Pharmacol Sin (2012) 0.78
Biodegradable microsphere-loaded tacrolimus enhanced the effect on mice islet allograft and reduced the adverse effect on insulin secretion. Am J Transplant (2004) 0.78
Anti-HIV-1 peptide derivatives based on the HIV-1 Co-receptor CXCR4. ChemMedChem (2013) 0.77
Real-time three-dimensional transesophageal echocardiography to predict artificial chordae length for mitral valve repair. J Cardiothorac Surg (2013) 0.77
[Current prevalence rate of congenital heart disease in 12 month-old and younger infants among four regions of Guangdong province]. Zhonghua Xin Xue Guan Bing Za Zhi (2013) 0.77
Fn14 promotes differentiation of human mesenchymal stem cells into heart valvular interstitial cells by phenotypic characterization. J Cell Physiol (2014) 0.77
Development of a clinically relevant animal model for the talar osteonecrosis in sheep. Int J Med Sci (2012) 0.77
The value of serum pepsinogen levels for the diagnosis of gastric diseases in Chinese Han people in midsouth China. BMC Gastroenterol (2014) 0.77
Natural antioxidant-isoliquiritigenin ameliorates contractile dysfunction of hypoxic cardiomyocytes via AMPK signaling pathway. Mediators Inflamm (2013) 0.77
Cell-permeable stapled peptides based on HIV-1 integrase inhibitors derived from HIV-1 gene products. ACS Chem Biol (2013) 0.77
CD28 superagonist-induced regulatory T cell expansion ameliorates mesangioproliferative glomerulonephritis in rats. Clin Exp Nephrol (2010) 0.77
A fetal goat model of cardiopulmonary bypass with cardioplegic arrest and hemodynamic assessment. J Thorac Cardiovasc Surg (2011) 0.77
Cloning, in vitro expression, and bioactivity of interleukin-18 isolated from a domestic porcine breed found in Henan. FEMS Immunol Med Microbiol (2009) 0.76
Survival of skin allografts is prolonged in mice with a dominant-negative H-Ras. Transpl Immunol (2007) 0.76
Immunological behavior of enhanced green fluorescent protein (EGFP) as a minor histocompatibility antigen with a special reference to skin isograft and specific regulation of local graft-versus-host reaction (GvHR). Immunol Lett (2009) 0.76
Luminal injection of hydrogen-rich solution attenuates intestinal ischemia-reperfusion injury in rats. Transplantation (2015) 0.76
Green-tea polyphenol (-)-epigallocatechin-3-gallate provides resistance to apoptosis in isolated islets. J Hepatobiliary Pancreat Surg (2007) 0.76
AdCTLA-4Ig combined with donor splenocytes, bone marrow cells and anti-ICOS antibody treatment induce tolerance in a rat heart transplantation model. Transpl Int (2003) 0.75
Mesenchymal stem cells attenuate rat graft-versus-host disease. Methods Mol Biol (2014) 0.75